BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 11688054)

  • 1. Partial integration raises antitrust concerns.
    Brock TH; Kamoie BE
    Healthc Financ Manage; 2000 Nov; 54(11):41-4. PubMed ID: 11688054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The legal framework for effective competition.
    Berenson RA; Hastings DA; Kopit WG
    Baxter Health Policy Rev; 1996; 2():235-65. PubMed ID: 11066262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitrust and affiliations among healthcare providers: the need for a level playing field.
    Heightchew A
    Hosp Health Serv Adm; 1997; 42(4):559-65. PubMed ID: 10174466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitrust concerns for physicians--not gone and not forgotten. Recent developments on the clinical integration front.
    Welch SS
    J Med Assoc Ga; 2009; 98(3):23-5. PubMed ID: 19714950
    [No Abstract]   [Full Text] [Related]  

  • 5. Government agencies soften stance on what constitutes price fixing.
    Ettinger DA; Lasser ML
    Healthc Financ Manage; 1997 Feb; 51(2):27-9. PubMed ID: 10164872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitrust and IDNs (integrated delivery networks): how far can we go?
    Campbell P
    Health Prog; 1993 Sep; 74(7):54-5, 65. PubMed ID: 10127984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing consolidation in healthcare markets: what are the antitrust policy implications?
    Haas-Wilson D; Gaynor M
    Health Serv Res; 1998 Dec; 33(5 Pt 2):1403-19. PubMed ID: 9865226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimizing antitrust exposure in a virtual merger.
    Brock TH
    Healthc Financ Manage; 1999 Sep; 53(9):38-44. PubMed ID: 11066705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Federal tax developments affecting health care organizations--Part II: New rulings and court decisions.
    Ing E
    Med Interface; 1997 Apr; 10(4):124-8, 146. PubMed ID: 10166798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avoid the antitrust trap: providers must study the law before they partner.
    Litwak P
    Behav Healthc Tomorrow; 1999 Aug; 8(4):19-23. PubMed ID: 10557691
    [No Abstract]   [Full Text] [Related]  

  • 11. Antitrust & health care reform.
    Bloch RE; Falk DM
    Caring; 1994 May; 13(5):44-7. PubMed ID: 10133865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration options.
    Williams L
    J Health Hosp Law; 1996; 29(2):88-96, 106. PubMed ID: 10160177
    [No Abstract]   [Full Text] [Related]  

  • 13. Juggling act. Six IT strategies for managing the IDS into the next century.
    Kastens JM; Gray SP
    Healthc Inform; 1998 Feb; 15(2):123-4, 126-7. PubMed ID: 10177669
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing an IDS's readiness to operate profitably under a risk contract.
    Garofalo WA
    Healthc Financ Manage; 2001 Feb; 55(2):41-5. PubMed ID: 11271441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clarify antitrust laws: AHA. Group discusses benefits of clinical integration practices.
    DoBias M
    Mod Healthc; 2007 Apr; 37(17):12. PubMed ID: 17477193
    [No Abstract]   [Full Text] [Related]  

  • 16. Negotiating roadblocks to IDS-physician equity joint ventures.
    Dubow SF; Benoff M
    Healthc Financ Manage; 1998 Sep; 52(9):35-7. PubMed ID: 10182740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avoiding antitrust snags requires forethought and thorough market analysis.
    Engstrom P
    Med Netw Strategy Rep; 1995 May; 4(5):1-4. PubMed ID: 10153138
    [No Abstract]   [Full Text] [Related]  

  • 18. Overcoming antitrust obstacles to integrated delivery.
    Marx D; Anthony MF
    Healthc Exec; 1997; 12(3):18-21. PubMed ID: 10166865
    [No Abstract]   [Full Text] [Related]  

  • 19. How intermediate tax sanctions may be applied to IDSs.
    Louthian RC
    Healthc Financ Manage; 1999 Apr; 53(4):33-6. PubMed ID: 10557976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospitals, group purchasing organizations, and the antitrust laws.
    Brock TH
    Healthc Financ Manage; 2003 Mar; 57(3):38-42. PubMed ID: 12747051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.